Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Gout and Hyperuricemia

Highly Access

Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

Robert Terkeltaub*, David A Bushinsky and Michael A Becker

Arthritis Research & Therapy 2006, 8(Suppl 1):S4 doi:10.1186/ar1909

Accesses  

  • Last 30 days: 106 accesses
  • Last 365 days: 1373 accesses
  • All time: 14182 accesses

Cited by